Alta Advisers’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.83M Hold
3,079
1.02% 16
2025
Q4
$3.31M Sell
3,079
-1,040
-25% -$994K 1.2% 16
2025
Q3
$3.14M Hold
4,119
0.96% 16
2025
Q2
$3.21M Hold
4,119
1.14% 16
2025
Q1
$3.4M Buy
4,119
+1,500
+57% +$1.25M 1.45% 15
2024
Q4
$2.02M Buy
2,619
+319
+14% +$264K 1.28% 15
2024
Q3
$2.04M Hold
2,300
0.93% 14
2024
Q2
$2.08M Hold
2,300
1% 11
2024
Q1
$1.79M Hold
2,300
0.89% 12
2023
Q4
$1.34M Buy
2,300
+200
+10% +$117K 0.72% 14
2023
Q3
$1.13M Hold
2,100
0.65% 15
2023
Q2
$985K Hold
2,100
0.55% 18
2023
Q1
$721K Hold
2,100
0.43% 23
2022
Q4
$768K Hold
2,100
0.46% 21
2022
Q3
$679K Buy
+2,100
New +$665K 0.43% 21

Other funds holding LLY

Alta Advisers's LLY Position: Q1 2026 in Review

Alta Advisers held its Eli Lilly (LLY) position steady in Q1 2026 at 3,079 shares worth $2.83M. The position accounts for 1.02% of the portfolio, ranked #16.

Alta Advisers first reported a position in LLY in Q3 2022 and has held it in 15 quarters since. The position peaked at $3.4M in Q1 2025. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Alta Advisers held 3,079 shares of Eli Lilly worth $2.83M as of Q1 2026.
  • Alta Advisers left its Eli Lilly share count unchanged in Q1 2026.
  • Eli Lilly made up 1.02% of Alta Advisers's portfolio in Q1 2026, its #16 holding.
  • Alta Advisers first reported a position in Eli Lilly in Q3 2022 and has held it in 15 quarters since.
  • Alta Advisers's Eli Lilly position peaked at $3.4M in Q1 2025.
  • 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Alta Advisers's 13F filing for Q1 2026, filed 7 May 2026.